范德特尼布作为潜在的抗炎和抗收缩剂在喘中
Xiaoyue Zeng1, Lu Xue1, Wei Li1
1Institute for Medical Biology and Hubei Provincial Key Laboratory for Protection and Application of Special Plants in Wuling Area of China, College of Life Sciences, South-Central Minzu University, Wuhan, China.
Frontiers in pharmacology
|May 27, 2024
概括
一种肺癌药物Vandetanib通过减少气道炎症和收缩,显示出它对喘治疗的前景. 这项研究探讨了它在缓解喘症状和病理变化的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 范德特尼布是一种用于肺癌治疗的氨酸激酶抑制剂.
- 它对喘等其他肺部疾病的疗效尚未得到充分证实.
- 这项研究探讨了范迪塔尼布在喘中的新疗法潜力.
研究的目的:
- 为了研究范德坦尼布在喘中的抗收缩和抗炎作用.
- 探索瓦德泰尼布在气道光滑肌肉中的作用背后的分子机制.
- 评估使用范德坦尼布治疗喘的可行性.
主要方法:
- 在体内喘小鼠模型来评估呼吸道阻力和炎症.
- 呼吸道病理学的组织学分析.
- 在体外实验包括肌肉张力测量和全细胞补丁记录以阐明分子标.
主要成果:
- 范德特尼布显著降低了喘小鼠的全身炎症和呼吸道病理变化.
- 它减轻了呼吸道过敏,过分分泌和重塑.
- 在体外,万迪塔尼布通过通过特定离子通道 (VDLCC,NSCC,NCX,K+通道) 调节动员来放松先前收缩的气管滑肌.
结论:
- 范德特尼布表现出与喘有关的显著抗收缩和抗炎性质.
- 药物的机制包括调节气道光滑肌肉中的通道.
- 这些发现表明,范德他尼布是喘治疗的潜在治疗候选者.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
273
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
273
Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
Antiasthma Drugs: Muscarinic Receptor Antagonists
286
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
286
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
Antiasthma Drugs: β2-Adrenoceptor Agonists
250
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
250
Asthma: Pathogenesis and Management
388
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
388


